- O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors. Kulke, M.H., Hornick, J.L., Frauenhoffer, C., Hooshmand, S., Ryan, D.P., Enzinger, P.C., Meyerhardt, J.A., Clark, J.W., Stuart, K., Fuchs, C.S., Redston, M.S. Clin. Cancer Res. (2009)